BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 28, 2011
View Archived Issues
Sanofi-aventis profiles progress of fourth quarter 2010
Read More
Additional phase II data reported on paclitaxel nanoparticles in urothelial cancer
Read More
Aestus begins phase II trial of ATx08-001 for neuropathic pain after shingles outbreak
Read More
Lux Biosciences begins enrollment in phase III voclosporin trial in uveitis
Read More
Global Health Ventures begins clinical development of X-Excite in E.U.
Read More
Lee's Pharma receives rights to Gaslon N in China
Read More
NCI develops anticancer monoclonal antibodies targeting mesothelin
Read More
Phase II pazopanib trial in urothelial cancer closed due to lack of activity
Read More
Rare Disease Day / Recently launched orphan drugs
Read More
Everolimus is active in patients with transitional cell carcinoma of the urothelium
Read More
New NICE guidance recommends not using Avastin for metastatic breast cancer
Read More
Stemline Therapeutics licenses phase I/II brain cancer vaccine
Read More
Enrollment complete in first of two pivotal phase III efficacy trials of LibiGel
Read More
CEQ-508 does not have adverse effects in nonhuman primates
Read More
AMG-386/sorafenib combination shows promise in metastatic renal cell carcinoma
Read More
MolMed extends pivotal phase III trial of NGR-hTNF
Read More
Phase II TXA-127 trial begins in autologous peripheral blood stem cell transplantation
Read More
PolyMedix completes phase I safety study of PMX-30063
Read More
Sanofi-aventis acquires BMP Sunstone
Read More
FDA grants Genentech hearing on Avastin for metastatic breast cancer
Read More
Belgian researchers disclose new inhibitors of HIV replication
Read More
Green Cross discloses (+)-3-hydroxymorphinans for neurodegenerative diseases
Read More
Takeda presents novel PARP inhibitors
Read More
New protein kinase inhibitors disclosed
Read More
Theravance presents new inhibitors of norepinephrine and/or 5-HT reuptake
Read More